Business Wire

GREAT-WALL-MOTOR

5.6.2019 11:19:08 CEST | Business Wire | Press release

Share
CZ-11 WEY Meets with a Great Success of China’s First-ever Sea Launch

At 12:06 on June 5, 2019, CZ-11 Solid-fuel Space Launch Vehicle (CZ-11 WEY) sees its first sea launch on the Yellow Sea, successfully sending seven satellites into the preset orbit and ushering in a new era of CASC development. The leading Chinese luxury SUV brand WEY is the first business partner of CASC. Both parties jointly call this launch vehicle as “CZ-11 WEY”, which marks a new breakthrough in business model of CASC. In addition, the Joint Technology Innovation Center co-initiated by CASC and WEY aims to put technologies into practice in the fields of quality system and testing, autonomous driving technology, new materials application and hydrogen energy through steady progress, so that the aero technology can be readily available.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190605005423/en/

CZ-11 Space Launch Vehicle is the first and only type of solid-fuel launch vehicles in the CZ Launch Vehicle Family. It is nearly 21 meters long and 58 tons weigh. Boasting a take-off thrust of 120 tons, it can carry up to 500 kg of payloads into the sun-synchronous orbit at a height of 500 km. This sea launch of CZ-11 WEY crystallizes the breakthroughs in a number of key technologies, such as wireless remote control at the front and rear terminals, independent intelligent security control on launcher, aiming of mobile base launching on the sea. CZ-11 Space Launch Vehicle has not only achieved China’s first-ever sea launch and low-inclination launch, but also created a new launch mode for Chinese launch vehicles into the space.

In conjunction with this sea launch, CASC and WEY steadily advance technical exchanges and cooperation in two fields. Both parties will promote integration in four fields of quality system and testing, autonomous driving technology, new materials application and hydrogen energy. They are committed to strongly empowering the independent R&D and manufacturing and creating greater market opportunities and economic value for CASC. Moreover, through technology application in the automotive industry, the aerospace technology can be readily available.

It is worth mentioning that Creative Experience Activity of “Dialogue with Parallel Universe” is jointly held by WEY and CASC. Through digital transmitter mounted on CZ-11 WEY Satellite, the voices of many consumers are transmitted to the outer space in the form of electric wave to “dialogue across the space” with another themselves in parallel universe. Compared with the international program of “Send Your Name to Mars with NASA’s next Mars Rover”, this sea launch is such a magnificent feat that retains the peoples’ voices and names in the space earlier.

Contact:

Great Wall Motor Liu Jian +8618241766066 liujian@dsconsulting.com

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SBC Medical Announces Pricing of Secondary Public Offering of 3.1 Million Shares of Common Stock20.4.2026 01:07:00 CEST | Press release

SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“the Company”), a Management Service Organization operating a wide range of franchise businesses across diverse medical fields, today announced the pricing of the underwritten secondary public offering of 3,100,000 shares of the Company’s common stock by Dr. Yoshiyuki Aikawa (the “Selling Stockholder”) at the public offering price of $3.25 per share. Additionally, the Selling Stockholder has granted the underwriters a 45-day option to purchase up to an additional 465,000 shares of the Company’s common stock. The offering is expected to close on or about April 21, 2026, subject to customary closing conditions. The Company is not selling any shares of its common stock in the offering. The Selling Stockholder will receive all of the proceeds from the offering. Maxim Group LLC is acting as the sole book-running manager and Roth Capital Partners is acting as the co-manager for the offering. The offering is being made pursuant to the Com

Horse Powertrain Reveals X-Range C15 Direct Drive Powertrain for Hybridizing BEV Platforms20.4.2026 01:01:00 CEST | Press release

Horse Powertrain, a global leader in innovative and low-emission powertrain systems, will unveil a new ‘all-in-one’ powertrain at Beijing Auto Show 2026: the X-Range C15 Direct Drive. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260419640202/en/ Left-facing view of the HORSE X-Range C15 Direct Drive The ultra-compact X-Range C15 Direct Drive integrates a full hybrid powertrain – including a 4-cylinder engine, transmission, power electronics, and an electric motor – into a single compact unit with a shared housing, designed to mount to the rear subframe enabling a double isolated installation for best NVH. The X-Range C15 Direct Drive is designed as an ‘all-in-one’ powertrain to replace the rear electric drive unit of an existing BEV platform. It enables an automaker to use a single shared platform for their BEV, HEV, PHEV, and REEV lineups without any significant changes to vehicle design or production environments. The ne

Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments18.4.2026 22:12:00 CEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, welcomes the White House Executive Order on accelerating medical treatments for serious mental illness. “We commend the Administration’s Executive Order on psychedelic treatment which recognizes the profound urgency of the mental health crisis facing millions of Americans and the potential impact FDA-approved psychedelics could have,” said Kabir Nath, CEO at Compass Pathways. “Today’s announcement aligns regulatory urgency with patient need, and we applaud the Administration for taking this important step forward in accelerating access, without compromising rigorous science. Compass is conducting the largest, most robust classic psychedelic studies to date with COMP360 synthetic psilocybin. We have recently reported two positive phase 3 trials in treatment-resistant depression (TRD) with highly statistically significant and clinically meaningful data that

2026 NAB Show Opens Tomorrow, Uniting Global Media Leaders to Shape the Future of Storytelling18.4.2026 04:08:00 CEST | Press release

CEO of Zhong, one of YouTube’s most-watched creators with 70 million subscribers and 95 million followers on all platforms, joins program The 2026 NAB Show kicks off Saturday, April 18, with the show floor and exhibits opening on April 19, highlighting the most innovative companies and bringing together the world’s most influential voices across media, entertainment and technology for the industry’s premier global event. As the only platform that convenes broadcasters, media companies, content creators and technology innovators at scale, NAB Show continues its century-long legacy as the catalyst for innovation, growth and deal-making in a rapidly evolving, multi-platform world. From artificial intelligence and the creator economy to sports, streaming and cloud transformation, NAB Show is where the tools, talent and ideas driving the future of storytelling converge. “NAB Show is where the global media ecosystem comes together not just to explore what’s next—but to build it,” said Karen

Philip Morris International Announces U.S. FDA Reauthorization of IQOS as a Modified Risk Tobacco Product17.4.2026 23:43:00 CEST | Press release

A pioneer in smoke-free tobacco products, Philip Morris International is the only company that has received modified risk tobacco product authorizations for heated tobacco products.In their order, FDA concluded that: “Scientific studies have shown that switching completely from conventional cigarettes to the IQOS system significantly reduces your body’s exposure to harmful or potentially harmful chemicals” The U.S. Food and Drug Administration (FDA) announced that it has authorized the renewal of modified risk tobacco product (MRTP) orders previously granted to PMI for two versions of the IQOS device and three variants of the tobacco consumables, commercialized under the HEETS brand. This renewal allows PMI to continue sharing reduced-exposure information with U.S. adults 21+ who use traditional tobacco products, such as combustible cigarettes. The agency concluded that renewing the IQOS and HEETS MRTP authorizations is appropriate to promote public health and is expected to benefit th

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye